Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.64 USD | -0.78% | +4.18% | +201.65% |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call | |
May. 13 | Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4 | MT |
Evolution of the average Target Price on Jasper Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Jasper Therapeutics, Inc.
HC Wainwright | |
Evercore ISI | |
RBC Capital Markets | |
TD Cowen | |
Capital One Securities | |
EF Hutton | |
Credit Suisse | |
Oppenheimer | |
Cantor Fitzgerald | |
William Blair & Co. | |
BMO Capital |
EPS Revisions
- Stock Market
- Equities
- JSPR Stock
- Consensus Jasper Therapeutics, Inc.